Vasconcelos, Joana C
137  results:
Search for persons X
?
3

Cost effectiveness of Ranibizumab vs Aflibercept vs Bevaciz..:

Pennington, Becky ; Alshreef, Abualbishr ; Flight, Laura...
Pennington , B , Alshreef , A , Flight , L , Metry , A , Poku , E , Hykin , P , Sivaprasad , S , Prevost , A T , Vasconcelos , J C , Murphy , C , Kelly , J , Yang , Y , Lotery , A , Williams , M & Brazier , J 2021 , ' Cost effectiveness of Ranibizumab vs Aflibercept vs Bevacizumab for the treatment of macular oedema due to central retinal vein occlusion: the LEAVO study ' , PharmacoEconomics , vol. 39 , no. 8 , pp. 913–927 . https://doi.org/10.1007/s40273-021-01026-5.  , 2021
 
?
4

Cost Effectiveness of Ranibizumab vs Aflibercept vs Bevaciz..:

Pennington, Becky ; Alshreef, Abualbishr ; Flight, Laura...
Pennington , B , Alshreef , A , Flight , L , Metry , A , Poku , E , Hykin , P , Sivaprasad , S , Prevost , A T , Vasconcelos , J C , Murphy , C , Kelly , J , Yang , Y , Lotery , A , Williams , M & Brazier , J 2021 , ' Cost Effectiveness of Ranibizumab vs Aflibercept vs Bevacizumab for the Treatment of Macular Oedema Due to Central Retinal Vein Occlusion : The LEAVO Study ' , PharmacoEconomics , vol. 39 , no. 8 , pp. 913-927 . https://doi.org/10.1007/s40273-021-01026-5.  , 2021
 
?
6

Intravitreal ranibizumab versus aflibercept versus bevacizu..:

Hykin, Philip ; Prevost, A. Toby ; Sivaprasad, Sobha...
Hykin , P , Prevost , A T , Sivaprasad , S , Vasconcelos , J C , Murphy , C , Kelly , J , Ramu , J , Alshreef , A , Flight , L , Pennington , R , Hounsome , B , Lever , E , Metry , A , Poku , E , Yang , Y , Harding , S P , Lotery , A , Chakravarthy , U & Brazier , J 2021 , ' Intravitreal ranibizumab versus aflibercept versus bevacizumab for macular oedema due to central retinal vein occlusion : the LEAVO non-inferiority three-arm RCT ' , Health technology assessment (Winchester, England) , vol. 25 , no. 38 , pp. VII-111 . https://doi.org/10.3310/hta25380.  , 2021
 
?
7

Correction to:Cost Effectiveness of Ranibizumab vs Afliberc..:

Pennington, Becky ; Alshreef, Abualbishr ; Flight, Laura...
Pennington , B , Alshreef , A , Flight , L , Metry , A , Poku , E , Hykin , P , Sivaprasad , S , Prevost , A T , Vasconcelos , J C , Murphy , C , Kelly , J , Yang , Y , Lotery , A , Williams , M & Brazier , J 2021 , ' Correction to : Cost Effectiveness of Ranibizumab vs Aflibercept vs Bevacizumab for the Treatment of Macular Oedema Due to Central Retinal Vein Occlusion: The LEAVO Study (PharmacoEconomics, (2021), 10.1007/s40273-021-01026-5) ' , PharmacoEconomics , vol. 39 , 1099 . https://doi.org/10.1007/s40273-021-01057-y.  , 2021
 
?
9

Cost Effectiveness of Ranibizumab vs Aflibercept vs Bevaciz..:

Pennington, Becky ; Alshreef, Abualbishr ; Flight, Laura...
Pennington , B , Alshreef , A , Flight , L , Metry , A , Poku , E , Hykin , P , Sivaprasad , S , Prevost , A T , Vasconcelos , J C , Murphy , C , Kelly , J , Yang , Y , Lotery , A , Williams , M & Brazier , J 2021 , ' Cost Effectiveness of Ranibizumab vs Aflibercept vs Bevacizumab for the Treatment of Macular Oedema Due to Central Retinal Vein Occlusion : The LEAVO Study ' , PharmacoEconomics , vol. 39 , no. 8 , pp. 913-927 . https://doi.org/10.1007/s40273-021-01026-5.  , 2021
 
?
10

Intravitreal ranibizumab versus aflibercept versus bevacizu..:

Hykin, Philip ; Prevost, A. Toby ; Sivaprasad, Sobha...
Hykin , P , Prevost , A T , Sivaprasad , S , Vasconcelos , J C , Murphy , C , Kelly , J , Ramu , J , Alshreef , A , Flight , L , Pennington , R , Hounsome , B , Lever , E , Metry , A , Poku , E , Yang , Y , Harding , S P , Lotery , A , Chakravarthy , U & Brazier , J 2021 , ' Intravitreal ranibizumab versus aflibercept versus bevacizumab for macular oedema due to central retinal vein occlusion : the LEAVO non-inferiority three-arm RCT ' , Health technology assessment (Winchester, England) , vol. 25 , no. 38 , pp. VII-111 . https://doi.org/10.3310/hta25380.  , 2021
 
?
12

Evaluation of a very brief pedometer-based physical activit..:

Hardeman, Wendy ; Mitchell, Joanna ; Pears, Sally...
https://eprints.whiterose.ac.uk/158231/1/journal.pmed.1003046.pdf.  , 2020
 
?
13

Evaluation of a very brief pedometer-based physical activit..:

Hardeman, Wendy ; Mitchell, Joanna ; Pears, Sally...
Hardeman , W , Mitchell , J , Pears , S , Van Emmenis , M , Theil , F , Gc , V S , Vasconcelos , J C , Westgate , K , Brage , S , Suhrcke , M , Griffin , S J , Kinmonth , A L , Wilson , E C F & Prevost , A T & Sutton , S 2020 , ' Evaluation of a very brief pedometer-based physical activity intervention delivered in NHS Health Checks in England : The VBI randomised controlled trial ' , PLoS Medicine , vol. 17 , no. 3 , e1003046 , pp. e1003046 . https://doi.org/10.1371/journal.pmed.1003046.  , 2020
 
?
14

Evaluation of a very brief pedometer-based physical activit..:

Hardeman, Wendy ; Mitchell, Joanna ; Pears, Sally...
Hardeman , W , Mitchell , J , Pears , S , Van Emmenis , M , Theil , F , Gc , V S , Vasconcelos , J C , Westgate , K , Brage , S , Suhrcke , M , Griffin , S J , Kinmonth , A L , Wilson , E C F & Prevost , A T & Sutton , S 2020 , ' Evaluation of a very brief pedometer-based physical activity intervention delivered in NHS Health Checks in England : The VBI randomised controlled trial ' , PLoS Medicine , vol. 17 , no. 3 , e1003046 , pp. e1003046 . https://doi.org/10.1371/journal.pmed.1003046.  , 2020
 
1-15